In the role of the General Manager, Michael set up the Swiss affiliate from scratch at Portola Pharmaceuticals. Previously, he was the European Launch Leader for an orphan disease asset at Celgene and built and managed business units at Celgene and AbbVie. Michael held various management positions at Roche and Essex/MSD and spent several years as a management consultant at The Boston Consulting Group. Michael holds a Master of Science in medical microbiology and a PhD in immunology from the University of Bern. He completed training programs at the HSG, INSEAD and the LBS and holds an Executive MBA in General Management from the University of Zurich.
Board of Directors
Swizzard Pharma AG is planning to appoint three members with broad and complementary industry experience to its Board of Directors. We will share more details following our shareholder meeting in the second quarter of 2021.
Our purpose is to enable healthy lives through sowing and growing of medical breakthroughs in Switzerland.